c-Ha-Ras mutants with point mutations in Gln-Val-Val region have reduced inhibitory activity toward cathepsin B

Cancer Lett. 1993 May 14;69(3):161-5. doi: 10.1016/0304-3835(93)90169-a.

Abstract

Protease-inhibitory activity of recombinant Ha-ras gene products (Ras) toward papain and cathepsins B and L was investigated. v-Ha-Ras showed more potent inhibitory activity toward cathepsin B as compared with c-Ha-Ras. We have also investigated protease-inhibitory activity of c-Ha-Ras mutants with point mutations in amino acids between positions 23 and 50. Inhibitory activity of Ras toward papain and cathepsin L was not largely altered among mutants. However, the inhibitory activity toward cathepsin B was significantly impaired by a mutation at position 43, 44, 45 or 48. These results suggest that 43Gln-Val-Val sequence plays an important role at least to inhibit cathepsin B.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Sequence
  • Cathepsin B / metabolism*
  • Cathepsin L
  • Cathepsins / metabolism*
  • Cysteine Endopeptidases
  • Endopeptidases*
  • Genes, ras / genetics*
  • Molecular Sequence Data
  • Oncogene Protein p21(ras) / metabolism*
  • Papain / metabolism*
  • Point Mutation*

Substances

  • Cathepsins
  • Endopeptidases
  • Cysteine Endopeptidases
  • Cathepsin B
  • Cathepsin L
  • Papain
  • Oncogene Protein p21(ras)